someone explain retatrutide to me like I have not read a paper in years
someone explain retatrutide to me like I have not read a paper in years. I would rather ask a basic question now than get this wrong quietly for two months. Glucagon receptor agonism is associated with increased energy expenditure and with hepatic effects. That is a mechanistic story with strong preclinical support…
research-use-only material is not approved for human use, full stop
Stopped at a low step because there was no reason to go further and no data to tell me what further would do.
Sent a vial to VendorInvestigate out of curiosity. Result was 99.1% against a claimed 99.0%, which is the first independent number I had seen for this compound anywhere.
[removed by moderator]
Push back: quoting the phase 2 headline as an expected outcome is not a fair reading of a small trial with wide intervals.
Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.
the escalation is where most of the reported trouble sits